+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Red Biotechnology Market 2024-2028

  • PDF Icon

    Report

  • 166 Pages
  • December 2023
  • Region: Global
  • TechNavio
  • ID: 5914235
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The red biotechnology market is forecasted to grow by USD 174.56 billion during 2023-2028, accelerating at a CAGR of 6.23% during the forecast period. The report on the red biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in genomic research, an increase in the prevalence of chronic diseases, and a growing aging population globally.

The red biotechnology market is segmented as below:

By Product

  • Monoclonal antibodies
  • Gene therapy
  • Polyclonal antibodies
  • Cell-based immunotherapy products
  • Others

By End-user

  • Pharmaceutical and biotechnology companies
  • CMOs and CROs
  • Academic research institutes

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising stem cell research and therapies as one of the prime reasons driving the red biotechnology market growth during the next few years. Also, the increasing production of biopharmaceuticals and therapeutic proteins and the rising prevalence of bioinformatics and data analytics will lead to sizable demand in the market.

The report on the red biotechnology market covers the following areas:

  • Red biotechnology market sizing
  • Red biotechnology market forecast
  • Red biotechnology market industry analysis
The robust vendor analysis is designed to help clients improve their market position. In line with this, this report provides a detailed analysis of several leading red biotechnology market vendors that include Amgen Inc., Astellas Pharma Inc., AstraZeneca Plc, Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Bruker Corp., CRISPR Therapeutics AG, Editas Medicine Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Merck KGaA, Mesoblast Ltd., Moderna Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., STEMCELL Technologies Inc., and Teva Pharmaceutical Industries Ltd.. Also, the red biotechnology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global red biotechnology market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global red biotechnology market 2018 - 2022 ($ billion)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Monoclonal antibodies - Market size and forecast 2023-2028
Exhibit 34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
6.4 Gene therapy - Market size and forecast 2023-2028
Exhibit 38: Chart on Gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
6.5 Polyclonal antibodies - Market size and forecast 2023-2028
Exhibit 42: Chart on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
6.6 Cell-based immunotherapy products - Market size and forecast 2023-2028
Exhibit 46: Chart on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
6.7 Others - Market size and forecast 2023-2028
Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Product
Exhibit 54: Market opportunity by Product ($ billion)
Exhibit 55: Data Table on Market opportunity by Product ($ billion)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 56: Chart on End-user - Market share 2023-2028 (%)
Exhibit 57: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 58: Chart on Comparison by End-user
Exhibit 59: Data Table on Comparison by End-user
7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
Exhibit 60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
7.4 CMOs and CROs - Market size and forecast 2023-2028
Exhibit 64: Chart on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on CMOs and CROs - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on CMOs and CROs - Year-over-year growth 2023-2028 (%)
7.5 Academic research institutes - Market size and forecast 2023-2028
Exhibit 68: Chart on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Data Table on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibit 70: Chart on Academic research institutes - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Academic research institutes - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 72: Market opportunity by End-user ($ billion)
Exhibit 73: Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 107: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 Germany - Market size and forecast 2023-2028
Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Amgen Inc.
Exhibit 123: Amgen Inc. - Overview
Exhibit 124: Amgen Inc. - Product / Service
Exhibit 125: Amgen Inc. - Key offerings
12.4 Astellas Pharma Inc.
Exhibit 126: Astellas Pharma Inc. - Overview
Exhibit 127: Astellas Pharma Inc. - Product / Service
Exhibit 128: Astellas Pharma Inc. - Key news
Exhibit 129: Astellas Pharma Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 130: AstraZeneca Plc - Overview
Exhibit 131: AstraZeneca Plc - Product / Service
Exhibit 132: AstraZeneca Plc - Key news
Exhibit 133: AstraZeneca Plc - Key offerings
12.6 Bayer AG
Exhibit 134: Bayer AG - Overview
Exhibit 135: Bayer AG - Business segments
Exhibit 136: Bayer AG - Key news
Exhibit 137: Bayer AG - Key offerings
Exhibit 138: Bayer AG - Segment focus
12.7 Biogen Inc.
Exhibit 139: Biogen Inc. - Overview
Exhibit 140: Biogen Inc. - Product / Service
Exhibit 141: Biogen Inc. - Key offerings
12.8 Boehringer Ingelheim International GmbH
Exhibit 142: Boehringer Ingelheim International GmbH - Overview
Exhibit 143: Boehringer Ingelheim International GmbH - Business segments
Exhibit 144: Boehringer Ingelheim International GmbH - Key news
Exhibit 145: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 146: Boehringer Ingelheim International GmbH - Segment focus
12.9 Bristol Myers Squibb Co.
Exhibit 147: Bristol Myers Squibb Co. - Overview
Exhibit 148: Bristol Myers Squibb Co. - Product / Service
Exhibit 149: Bristol Myers Squibb Co. - Key news
Exhibit 150: Bristol Myers Squibb Co. - Key offerings
12.10 Bruker Corp.
Exhibit 151: Bruker Corp. - Overview
Exhibit 152: Bruker Corp. - Business segments
Exhibit 153: Bruker Corp. - Key news
Exhibit 154: Bruker Corp. - Key offerings
Exhibit 155: Bruker Corp. - Segment focus
12.11 F. Hoffmann La Roche Ltd.
Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus
12.12 Gilead Sciences Inc.
Exhibit 161: Gilead Sciences Inc. - Overview
Exhibit 162: Gilead Sciences Inc. - Product / Service
Exhibit 163: Gilead Sciences Inc. - Key news
Exhibit 164: Gilead Sciences Inc. - Key offerings
12.13 Merck KGaA
Exhibit 165: Merck KGaA - Overview
Exhibit 166: Merck KGaA - Business segments
Exhibit 167: Merck KGaA - Key news
Exhibit 168: Merck KGaA - Key offerings
Exhibit 169: Merck KGaA - Segment focus
12.14 Pfizer Inc.
Exhibit 170: Pfizer Inc. - Overview
Exhibit 171: Pfizer Inc. - Product / Service
Exhibit 172: Pfizer Inc. - Key news
Exhibit 173: Pfizer Inc. - Key offerings
12.15 Regeneron Pharmaceuticals Inc.
Exhibit 174: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 175: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 176: Regeneron Pharmaceuticals Inc. - Key offerings
12.16 STEMCELL Technologies Inc.
Exhibit 177: STEMCELL Technologies Inc. - Overview
Exhibit 178: STEMCELL Technologies Inc. - Product / Service
Exhibit 179: STEMCELL Technologies Inc. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 180: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 181: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 182: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 183: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 184: Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 185: Inclusions checklist
Exhibit 186: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 187: Currency conversion rates for US$
13.4 Research methodology
Exhibit 188: Research methodology
Exhibit 189: Validation techniques employed for market sizing
Exhibit 190: Information sources
13.5 List of abbreviations
Exhibit 191: List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 18: Historic Market Size - Data Table on global red biotechnology market 2018 - 2022 ($ billion)
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
Exhibit 34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibit 38: Chart on Gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)
Exhibit 42: Chart on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibit 46: Chart on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibit 54: Market opportunity by Product ($ billion)
Exhibit 55: Data Table on Market opportunity by Product ($ billion)
Exhibit 56: Chart on End-user - Market share 2023-2028 (%)
Exhibit 57: Data Table on End-user - Market share 2023-2028 (%)
Exhibit 58: Chart on Comparison by End-user
Exhibit 59: Data Table on Comparison by End-user
Exhibit 60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibit 64: Chart on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on CMOs and CROs - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on CMOs and CROs - Year-over-year growth 2023-2028 (%)
Exhibit 68: Chart on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Data Table on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibit 70: Chart on Academic research institutes - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Academic research institutes - Year-over-year growth 2023-2028 (%)
Exhibit 72: Market opportunity by End-user ($ billion)
Exhibit 73: Data Table on Market opportunity by End-user ($ billion)
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 75: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibit 107: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibit 117: Impact of drivers and challenges in 2023 and 2028
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
Exhibit 119: Overview on factors of disruption
Exhibit 120: Impact of key risks on business
Exhibit 121: Vendors covered
Exhibit 122: Matrix on vendor position and classification
Exhibit 123: Amgen Inc. - Overview
Exhibit 124: Amgen Inc. - Product / Service
Exhibit 125: Amgen Inc. - Key offerings
Exhibit 126: Astellas Pharma Inc. - Overview
Exhibit 127: Astellas Pharma Inc. - Product / Service
Exhibit 128: Astellas Pharma Inc. - Key news
Exhibit 129: Astellas Pharma Inc. - Key offerings
Exhibit 130: AstraZeneca Plc - Overview
Exhibit 131: AstraZeneca Plc - Product / Service
Exhibit 132: AstraZeneca Plc - Key news
Exhibit 133: AstraZeneca Plc - Key offerings
Exhibit 134: Bayer AG - Overview
Exhibit 135: Bayer AG - Business segments
Exhibit 136: Bayer AG - Key news
Exhibit 137: Bayer AG - Key offerings
Exhibit 138: Bayer AG - Segment focus
Exhibit 139: Biogen Inc. - Overview
Exhibit 140: Biogen Inc. - Product / Service
Exhibit 141: Biogen Inc. - Key offerings
Exhibit 142: Boehringer Ingelheim International GmbH - Overview
Exhibit 143: Boehringer Ingelheim International GmbH - Business segments
Exhibit 144: Boehringer Ingelheim International GmbH - Key news
Exhibit 145: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 146: Boehringer Ingelheim International GmbH - Segment focus
Exhibit 147: Bristol Myers Squibb Co. - Overview
Exhibit 148: Bristol Myers Squibb Co. - Product / Service
Exhibit 149: Bristol Myers Squibb Co. - Key news
Exhibit 150: Bristol Myers Squibb Co. - Key offerings
Exhibit 151: Bruker Corp. - Overview
Exhibit 152: Bruker Corp. - Business segments
Exhibit 153: Bruker Corp. - Key news
Exhibit 154: Bruker Corp. - Key offerings
Exhibit 155: Bruker Corp. - Segment focus
Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 161: Gilead Sciences Inc. - Overview
Exhibit 162: Gilead Sciences Inc. - Product / Service
Exhibit 163: Gilead Sciences Inc. - Key news
Exhibit 164: Gilead Sciences Inc. - Key offerings
Exhibit 165: Merck KGaA - Overview
Exhibit 166: Merck KGaA - Business segments
Exhibit 167: Merck KGaA - Key news
Exhibit 168: Merck KGaA - Key offerings
Exhibit 169: Merck KGaA - Segment focus
Exhibit 170: Pfizer Inc. - Overview
Exhibit 171: Pfizer Inc. - Product / Service
Exhibit 172: Pfizer Inc. - Key news
Exhibit 173: Pfizer Inc. - Key offerings
Exhibit 174: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 175: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 176: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibit 177: STEMCELL Technologies Inc. - Overview
Exhibit 178: STEMCELL Technologies Inc. - Product / Service
Exhibit 179: STEMCELL Technologies Inc. - Key offerings
Exhibit 180: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 181: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 182: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 183: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 184: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibit 185: Inclusions checklist
Exhibit 186: Exclusions checklist
Exhibit 187: Currency conversion rates for US$
Exhibit 188: Research methodology
Exhibit 189: Validation techniques employed for market sizing
Exhibit 190: Information sources
Exhibit 191: List of abbreviations

Executive Summary

The analyst recognizes the following companies as the key players in the global red biotechnology market: Amgen Inc., Astellas Pharma Inc., AstraZeneca Plc, Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Bruker Corp., CRISPR Therapeutics AG, Editas Medicine Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Merck KGaA, Mesoblast Ltd., Moderna Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., STEMCELL Technologies Inc., and Teva Pharmaceutical Industries Ltd.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising stem cell research and therapies.'

According to the report, one of the major drivers for this market is the advancements in genomic research.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Co.
  • Bruker Corp.
  • CRISPR Therapeutics AG
  • Editas Medicine Inc.
  • F. Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • Merck KGaA
  • Mesoblast Ltd.
  • Moderna Inc.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • STEMCELL Technologies Inc.
  • Teva Pharmaceutical Industries Ltd.